MDPIT
MDPIT
Multicentre Diltiazem Post Infarction Trial. A clinical trial in which patients age 25–75 were randomised post-acute myocardial infarction to receive either diltiazem, a calcium channel blocker, or a placebo.Conclusion
MDPIT concluded that patients with pulmonary congestion or reduced ejection fraction did less well with diltiazem; those without these risk factors had a marginally significant reduction in cardiac events at one year of follow-up.